• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素AT1受体拮抗剂CV-11974可调节脑血流量及脑内血管紧张素AT1受体的表达。

The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.

作者信息

Nishimura Y, Xu T, Jöhren O, Häuser W, Saavedra J M

机构信息

Section on Pharmacology, National Institute of Mental Health, Bethesda, MD 20892-1264, USA.

出版信息

Basic Res Cardiol. 1998;93 Suppl 2:63-8. doi: 10.1007/s003950050221.

DOI:10.1007/s003950050221
PMID:9833166
Abstract

We studied cerebral blood flow autoregulation by laser Doppler flowmetry, and expression of brain angiotensin II AT1 receptors by quantitative autoradiography, after administration of an angiotensin AT1 receptor antagonist, CV-11974 (Candesartan, 0.5 or 1.0 mg/kg.day) for two weeks via subcutaneously implanted osmotic pumps in adult normotensive Wistar Kyoto and spontaneously hypertensive male rats (SHR). In SHR, the autoregulation curve was shifted towards higher blood pressures, when compared with that of normotensive Wistar Kyoto rats. Administration of CV-11974 shifted the autoregulation curve toward lower blood pressures in both Wistar Kyoto and SHR, partially normalizing the autoregulation curve in SHR. CV-11974 treatment markedly decreased the expression of AT1 receptors in Wistar Kyoto rats, both in areas outside the blood brain barrier (subfornical organ, 95% decrease) and inside the blood brain barrier (nucleus of the tractus solitarius, 87% decrease, and paraventricular nucleus, 96% decrease). Our results demonstrate that blockade of AT1 receptors tends to normalize the shift to higher pressures in the autoregulation curve of genetically hypertensive rats, and has a profound modulatory role in brain angiotensin II AT1 receptors.

摘要

我们通过激光多普勒血流测定法研究了脑血流自动调节,并通过定量放射自显影法研究了脑内血管紧张素II AT1受体的表达。在成年正常血压的Wistar Kyoto大鼠和自发性高血压雄性大鼠(SHR)中,通过皮下植入渗透泵给予血管紧张素AT1受体拮抗剂CV-11974(坎地沙坦,0.5或1.0mg/kg·天)两周。与正常血压的Wistar Kyoto大鼠相比,SHR的自动调节曲线向更高血压偏移。给予CV-11974可使Wistar Kyoto大鼠和SHR的自动调节曲线向更低血压偏移,部分使SHR的自动调节曲线正常化。CV-11974治疗显著降低了Wistar Kyoto大鼠血脑屏障外区域(穹窿下器官,降低95%)和血脑屏障内区域(孤束核,降低87%,室旁核,降低96%)的AT1受体表达。我们的结果表明,阻断AT1受体倾向于使遗传性高血压大鼠自动调节曲线向更高压力偏移正常化,并对脑内血管紧张素II AT1受体具有深远的调节作用。

相似文献

1
The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.血管紧张素AT1受体拮抗剂CV-11974可调节脑血流量及脑内血管紧张素AT1受体的表达。
Basic Res Cardiol. 1998;93 Suppl 2:63-8. doi: 10.1007/s003950050221.
2
Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.血管紧张素II 1型受体阻断可使自发性高血压大鼠的脑血管自动调节恢复正常,并减轻脑缺血。
Stroke. 2000 Oct;31(10):2478-86. doi: 10.1161/01.str.31.10.2478.
3
Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.血管紧张素II受体拮抗剂CV-11974与脑血流自动调节
J Hypertens. 1995 Jul;13(7):755-61.
4
Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.通过抑制血管紧张素II AT1受体使自发性高血压大鼠脑微血管内皮型和诱导型一氧化氮合酶表达正常化。
J Cereb Blood Flow Metab. 2003 Mar;23(3):371-80. doi: 10.1097/01.WCB.0000047369.05600.03.
5
Pre-treatment with candesartan protects from cerebral ischaemia.坎地沙坦预处理可预防脑缺血。
J Renin Angiotensin Aldosterone Syst. 2001 Sep;2(3):174-9. doi: 10.3317/jraas.2001.024.
6
Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.在自发性高血压大鼠中,急性或慢性中枢给予AT1受体拮抗剂后缺乏中枢介导的降压作用。
Br J Pharmacol. 1995 Dec;116(8):3181-90. doi: 10.1111/j.1476-5381.1995.tb15122.x.
7
AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.血管紧张素Ⅱ 1型受体拮抗剂可对抗氧化应激并恢复自发性高血压大鼠的一氧化氮信号传导。
Kidney Int. 2001 Apr;59(4):1257-63. doi: 10.1046/j.1523-1755.2001.0590041257.x.
8
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.通过用血管紧张素II AT1拮抗剂进行慢性预处理,对遗传性高血压大鼠进行缺血保护并改善脑血流量。
Stroke. 2002 Sep;33(9):2297-303. doi: 10.1161/01.str.0000027274.03779.f3.
9
AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.AT1受体阻断可调节自发性高血压大鼠脑微血管中的局部血管紧张素II系统。
Stroke. 2006 May;37(5):1271-6. doi: 10.1161/01.STR.0000217404.64352.d7. Epub 2006 Apr 6.
10
Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats.坎地沙坦可使年轻自发性高血压大鼠过度活跃的球管反馈活动恢复正常。
J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S213-9.

引用本文的文献

1
Both central sympathoexcitation and peripheral angiotensin II-dependent vasoconstriction contribute to hypertension development in immature heterozygous Ren-2 transgenic rats.中枢交感兴奋和外周血管紧张素 II 依赖性血管收缩均有助于未成年杂合 Ren-2 转基因大鼠高血压的发展。
Hypertens Res. 2022 Mar;45(3):414-423. doi: 10.1038/s41440-021-00775-2. Epub 2021 Oct 8.
2
Cognitive impact of COVID-19: looking beyond the short term.新冠疫情对认知功能的影响:关注短期之外。
Alzheimers Res Ther. 2020 Dec 30;12(1):170. doi: 10.1186/s13195-020-00744-w.
3
Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.
脑源性血管紧张素II:新进展、未解决的问题及治疗机遇
Cell Mol Neurobiol. 2005 Jun;25(3-4):485-512. doi: 10.1007/s10571-005-4011-5.
4
Angiotensin and cerebral blood flow.血管紧张素与脑血流量。
Cell Mol Neurobiol. 1999 Oct;19(5):553-73. doi: 10.1023/a:1006995016403.